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ess: chink@kuhp.kyoto-Summary Hepatic hydrothorax is defined as pleural effusion with liver cirrhosis
but no primary cardiopulmonary disease. Hepatic hydrothorax is often resistant to
various therapeutic interventions. The most likely cause is the transfer of ascites
fluid from the abdomen to the pleural space via the diaphragm because of a negative
intrathoracic pressure gradient. A 62-year-old man was diagnosed with hepatoma
and cirrhosis. After a partial hepatectomy, he suffered with hepatic hydrothorax. He
had snoring without obvious sleep apnea. The patient’s hepatic hydrothorax
markedly improved following nasal continuous positive airway pressure (nCPAP)
treatment during sleep. The mechanism for the improvement may have been the
intrathoracic positive pressure during sleep induced by the nCPAP treatment during
sleep. nCPAP treatment may provide a new therapy for resistant hepatic
hydrothorax.
& 2004 Elsevier Ltd. All rights reserved.Introduction
About 6% of cirrhotic patients have a significant
pleural effusion.1,2 The effusion in a patient with
liver cirrhosis but no primary cardiac or pulmonaryElsevier Ltd. All rights reserv
751-3852; fax: +81-75751-
u.ac.jp (K. Chin).disease is called hepatic hydrothorax (HH). Ascites
exists to some degree in most patients with
progressive liver cirrhosis, and it permeates the
diaphragm, moving into the pleural space.3 The
conventional management of this condition consists
of sodium restriction, diuretics, thoracentesis, and
pleurodesis. But the effusion is difficult to elim-
inate because it continuously shifts from the
abdomen into the pleural cavity as a result of theed.
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tive airway pressure (nCPAP) treatment in an HH
patient who had habitual snoring, and his HH
markedly improved. nCPAP converts the negative
intrathoracic pressure to positive4 and may prevent
the shifts of fluid.Case report
A 62-year-old man, who was a carrier of the
hepatitis type B virus, was diagnosed with hepato-
ma. He underwent a partial hepatectomy in Kyoto
University Hospital. Pathological examination
showed severe liver cirrhosis and poorly differen-
tiated hepatocellular carcinoma. The patient made
good progress after the operation but had right-
sided pleural effusion and passive atelectasis. After
release from the hospital, two months of careful
observation and sodium restriction with diuretics
could not reduce the pleural effusion.
His chest radiograph and computed tomography
on re-admission showed pleural effusion and
slight atelectasis on the right side (Fig. 1A–C). His
body mass index was 24.7 kg/m2. Electrocardio-
gram and cardioechography showed no cardiac
failure. Abdominal echography revealed slightFigure 1 (A) Chest radiography on admission shows right pleu
position shows massive effusion. (C) Chest computed tomog
Chest radiography on day 50 after usage of nCPAP shows noascites. Laboratory tests showed mild liver damage
(aspartate aminotransferase 96 IU/L, alanine ami-
notransferase 104 IU/L) and hypothrombocythemia
(95 109/L). Neither inflammation nor renal dys-
function were detected. Effusion was transudative
and there was no sign of malignancy or infection.
Bronchofiberscopy showed no apparent airway
obstruction causing the local lung collapse. The
first step of treatment for pleural effusion is to
restrict daily sodium intake and to adminis-
ter diuretics. His weight reduced slightly
(63.0–60.5 kg in a week) but his effusion was not
reduced by the standard therapy.
The patient had habitual snoring without daytime
sleepiness. His night oximetry had a43% desatura-
tion index of 4.6 per hour. Since it has been
reported that negative intrathoracic pressure dur-
ing snoring is high, 5 cm H2O of nCPAP (ResMed,
NSW, Australia) was used at night to convert the
negative intrathoracic pressure to positive.
The43% desaturation index with nCPAP decreased
to 1.7 per hour and his snoring ceased. One week
later, we found the effusion had decreased re-
markably and the lung collapse disappeared on
chest radiograph but his weight did not change
(60.5–60.0 kg). After the near elimination of the
effusion (Fig. 1D), the patient left the hospital.ral effusion. (B) Chest radiography in the right decubitus
raphy shows right pleural effusion and lung collapse. (D)
pleural effusion.
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nCPAP use at night. After one month, the pleural
effusion returned. He resumed using nCPAP at night
and the HH again improved.Discussion
This habitual snorer with resistant HH improved
with nCPAP treatment during sleep. Snoring in
middle-aged patients is very common. Therefore,
the incidence of concurring HH and snoring may be
considerable. nCPAP treatment may provide a new
therapy for resistant HH in addition to the usual
medical care.
The most likely cause of HH is a direct transfer of
fluid from the abdomen to the pleural space via
defects in the diaphragm. The diaphragm can have
defects both grossly and microscopically. Surgical
procedures on the liver, of course, result in
additional injuries to the diaphragm. The patho-
physiology of ascites formation involves fluid leak-
ing from the liver into the peritoneal cavity. The
ascites collects around the liver, which is closely
applied to the undersurface of the right hemi-
diaphragm. The negative pressure of the pleural
space relative to the peritoneal cavity favors the
one-way transfer of fluid across these defects and
its subsequent trapping within the pleural space. In
this case, hepatectomy may have induced addi-
tional defects in the diaphragm and further
decreased the liver function.
The first step of treatment is to restrict daily
sodium intake and to administer diuretics. But this
therapy is often ineffective. Thoracentesis is
effective for pulmonary symptoms but this therapy
is temporary because of the inexhaustible supply of
ascites fluid. Moreover it increases the risk for
hypoproteinenia, dehydration, infection, and other
complications.5 Pleurodesis is usually unsuccessful
because of the rapid re-supply of the effusion from
the abdominal cavity. Other invasive therapies,
such as repair of the diaphragm defects byvideothoracoscopy and peritoneovenous shunts
have also been tried but with only marginal
success.1,6 Our findings suggest that conversion of
the intrathoracic pressure from negative to positive
might offer a new strategy to control HH.
The prevalence of snoring is reported to be high,
sometimes estimated to be as high as 83%.7 There-
fore, the prevalence of HH patients with snoring
would also be expected to be high. It has been
reported that intrathoracic negative pressure be-
come worse during snoring,8 which would exacer-
bate the HH. Although this is only the report of a
single case, the pleural effusion returned after
stopping the nCPAP, and improved after nCPAP re-
treatment. Further clinical research would need to
establish nCPAP therapy as the appropriate therapy
for HH, but we recommend this treatment for
resistant HH in addition to the usual medical
treatment because nCPAP treatment is noninvasive
for almost all patients.References
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